Manual 1625M Revision B Revision Date: February 16, 2007
For research use only. Not for use in diagnostic procedures. By use of this product, you accept the terms and
conditions of all applicable Limited Label Licenses. For statement(s) and/or disclaimer(s) applicable to this
product, see below.
Literature Citation
When describing a procedure for publication using this product, we would appreciate that you refer
to it as the
Silencer
®
siRNA Cocktail Kit (RNase III).
If a paper that cites one of Ambion’s products is published in a research journal, the author(s) may receive a free Ambion T-
shirt by sending in the completed form at the back of this instruction manual, along with a copy of the paper.
Warranty and Liability
Ambion is committed to providing the highest quality reagents at competitive prices. Ambion
warrants that for the earlier of (i) one (1) year from the date of shipment or (ii) until the shelf life date, expiration date, “use
by” date, “guaranty date”, or other end-of-recommended-use date stated on the product label or in product literature that
accompanies shipment of the product, Ambion's products meet or exceed the performance standards described in the prod-
uct specification sheets if stored and used properly. No other warranties of any kind, expressed or implied, are provided by
Ambion. WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE ARE
EXPRESSLY DISCLAIMED. AMBION'S LIABILITY SHALL NOT EXCEED THE PURCHASE PRICE OF THE
PRODUCT. AMBION SHALL HAVE NO LIABILITY FOR INDIRECT, CONSEQUENTIAL, OR INCIDENTAL
DAMAGES ARISING FROM THE USE, RESULTS OF USE, OR INABILITY TO USE ITS PRODUCTS. See the full
limited warranty statement that accompanies products for full terms, conditions and limitations of Ambion's limited prod-
uct warranty, or contact Ambion for a copy.
Patents and Licensing Notifications
The
Silencer
®
siRNA Cocktail Kit (RNase III) is covered by US patents and for-
eign patents pending. Ambion has been granted rights by the Massachusetts Institute of Technology to US Patent Applica-
tions 60/265232, 09/821832 and PCT/US01/10188, RNA Sequence-Specific Mediators of RNA Interference.
This product is covered by several patent applications owned by STANFORD. The purchase of this product conveys the
buyer the limited, non-exclusive, non-transferable right (without the right to resell, repackage, or further sublicense) under
these patent rights to perform the siRNA production methods claimed in those patent applications for research purposes
solely in conjunction with this product. No other license is granted to the buyer whether expressly, by implication, by
estoppel or otherwise. In particular, the purchase of this product does not include nor carry any right or license to use,
develop, otherwise exploit this product commercially, and no rights are conveyed to the buyer to use the product or compo-
nents of the product for any other purposes, including without limitation, provision of services to a third party, generation
of commercial databases, or clinical diagnostics or therapeutics.
In addition, any user that purchases more that $5,000 in any calendar quarter may be outside the above research license and
will contact STANFORD for a license.
This product is sold pursuant to a license from STANFORD, and STANFORD reserves all other rights under these patent
rights. For information on purchasing a license to the patent rights for uses other than in conjunction with this product or
to use this product for purposes other than research, please contact STANFORD at, 650-723-0651. This is STANFORD
reference S02-028.
This product is licensed under European Patents 1144623, 1214945 and foreign equivalents from Alnylam Pharmaceuticals,
Inc., Cambridge, USA and is provided only for use in academic and commercial research including in vitro and in vivo iden-
tification and validation of drug targets (but excluding the evaluation or characterization of this product as the potential basis
for a siRNA-based drug) and not for any other commercial purposes. Information about licenses for commercial use (includ-
ing discovery and development of siRNA-based drugs) is available from Alnylam Pharmaceuticals, Inc., 300 Third Street,
Cambridge, MA 02142, USA.
Ambion/AB Trademarks
Applied Biosystems, AB (Design), and Applera are registered trademarks of Applera
Corporation or its subsidiaries in the US and/or certain other countries. Ambion, The RNA Company,
Silencer
, MEGAscript and RNase
Zap
are registered trademarks of Ambion, Inc. in the U.S. and/or certain
other countries. All other trademarks are the sole property of their respective owners.
© Copyright (2007) by Ambion, Inc., an Applied Biosystems Business. All Rights Reserved.